Identification of STAT target genes in adipocytes

References

• Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 2011; 12:722 - 34; http://dx.doi.org/10.1038/nrm3198; PMID: 21952300
   PubMed Web of Science ®Google Scholar
• Sarjeant K, Stephens JM. Adipogenesis. Cold Spring Harb Perspect Biol 2012; 4:a008417; http://dx.doi.org/10.1101/cshperspect.a008417; PMID: 22952395
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr.. STATs and gene regulation. Science 1997; 277:1630 - 5; http://dx.doi.org/10.1126/science.277.5332.1630; PMID: 9287210
   PubMed Web of Science ®Google Scholar
• Schindler C, Darnell JE Jr.. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995; 64:621 - 51; http://dx.doi.org/10.1146/annurev.bi.64.070195.003201; PMID: 7574495
   PubMed Web of Science ®Google Scholar
• Stark GR, Darnell JE Jr.. The JAK-STAT pathway at twenty. Immunity 2012; 36:503 - 14; http://dx.doi.org/10.1016/j.immuni.2012.03.013; PMID: 22520844
   PubMed Web of Science ®Google Scholar
• Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, et al. Function of mitochondrial Stat3 in cellular respiration. Science 2009; 323:793 - 7; http://dx.doi.org/10.1126/science.1164551; PMID: 19131594
   PubMed Web of Science ®Google Scholar
• Stephens JM, Morrison RF, Pilch PF. The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J Biol Chem 1996; 271:10441 - 4; http://dx.doi.org/10.1074/jbc.271.18.10441; PMID: 8631837
   PubMed Web of Science ®Google Scholar
• Harp JB, Franklin D, Vanderpuije AA, Gimble JM. Differential expression of signal transducers and activators of transcription during human adipogenesis. Biochem Biophys Res Commun 2001; 281:907 - 12; http://dx.doi.org/10.1006/bbrc.2001.4460; PMID: 11237746
   PubMed Web of Science ®Google Scholar
• Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996; 84:431 - 42; http://dx.doi.org/10.1016/S0092-8674(00)81288-X; PMID: 8608597
   PubMed Web of Science ®Google Scholar
• Deng J, Hua K, Lesser SS, Harp JB. Activation of signal transducer and activator of transcription-3 during proliferative phases of 3T3-L1 adipogenesis. Endocrinology 2000; 141:2370 - 6; http://dx.doi.org/10.1210/en.141.7.2370; PMID: 10875236
   PubMed Web of Science ®Google Scholar
• Deng J, Hua K, Caveney EJ, Takahashi N, Harp JB. Protein inhibitor of activated STAT3 inhibits adipogenic gene expression. Biochem Biophys Res Commun 2006; 339:923 - 31; http://dx.doi.org/10.1016/j.bbrc.2005.10.217; PMID: 16329991
   PubMed Web of Science ®Google Scholar
• Zhang K, Guo W, Yang Y, Wu J. JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulating C/EBPβ transcription. J Cell Biochem 2011; 112:488 - 97; http://dx.doi.org/10.1002/jcb.22936; PMID: 21268070
   PubMed Web of Science ®Google Scholar
• Wang D, Zhou Y, Lei W, Zhang K, Shi J, Hu Y, et al. Signal transducer and activator of transcription 3 (STAT3) regulates adipocyte differentiation via peroxisome-proliferator-activated receptor gamma (PPARgamma). Biol Cell 2010; 102:1 - 12; http://dx.doi.org/10.1042/BC20090070; PMID: 19566485
   PubMed Web of Science ®Google Scholar
• Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JB. Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 2008; 149:1581 - 90; http://dx.doi.org/10.1210/en.2007-1148; PMID: 18096662
   PubMed Web of Science ®Google Scholar
• Wu Z, Bucher NL, Farmer SR. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol Cell Biol 1996; 16:4128 - 36; PMID: 8754811
   PubMed Web of Science ®Google Scholar
• Stephens JM, Morrison RF, Wu Z, Farmer SR. PPARgamma ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis. Biochem Biophys Res Commun 1999; 262:216 - 22; http://dx.doi.org/10.1006/bbrc.1999.0889; PMID: 10448095
   PubMed Web of Science ®Google Scholar
• Stewart WC, Morrison RF, Young SL, Stephens JM. Regulation of signal transducers and activators of transcription (STATs) by effectors of adipogenesis: coordinate regulation of STATs 1, 5A, and 5B with peroxisome proliferator-activated receptor-gamma and C/AAAT enhancer binding protein-alpha. Biochim Biophys Acta 1999; 1452:188 - 96; http://dx.doi.org/10.1016/S0167-4889(99)00129-9; PMID: 10559472
   PubMed Web of Science ®Google Scholar
• Yarwood SJ, Sale EM, Sale GJ, Houslay MD, Kilgour E, Anderson NG. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling. J Biol Chem 1999; 274:8662 - 8; http://dx.doi.org/10.1074/jbc.274.13.8662; PMID: 10085104
   PubMed Web of Science ®Google Scholar
• Shang CA, Waters MJ. Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes. Mol Endocrinol 2003; 17:2494 - 508; http://dx.doi.org/10.1210/me.2003-0139; PMID: 12970402
   PubMed Web of Science ®Google Scholar
• Nanbu-Wakao R, Morikawa Y, Matsumura I, Masuho Y, Muramatsu MA, Senba E, et al. Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5. Mol Endocrinol 2002; 16:1565 - 76; http://dx.doi.org/10.1210/me.16.7.1565; PMID: 12089351
   PubMed Web of Science ®Google Scholar
• Floyd ZE, Stephens JM. STAT5A promotes adipogenesis in nonprecursor cells and associates with the glucocorticoid receptor during adipocyte differentiation. Diabetes 2003; 52:308 - 14; http://dx.doi.org/10.2337/diabetes.52.2.308; PMID: 12540601
   PubMed Web of Science ®Google Scholar
• Kawai M, Namba N, Mushiake S, Etani Y, Nishimura R, Makishima M, et al. Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway. J Mol Endocrinol 2007; 38:19 - 34; http://dx.doi.org/10.1677/jme.1.02154; PMID: 17242167
   PubMed Web of Science ®Google Scholar
• Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998; 93:841 - 50; http://dx.doi.org/10.1016/S0092-8674(00)81444-0; PMID: 9630227
   PubMed Web of Science ®Google Scholar
• Stewart WC, Pearcy LA, Floyd ZE, Stephens JM. STAT5A expression in Swiss 3T3 cells promotes adipogenesis in vivo in an athymic mice model system. Obesity (Silver Spring) 2011; 19:1731 - 4; http://dx.doi.org/10.1038/oby.2011.66; PMID: 21494231
   PubMed Web of Science ®Google Scholar
• White UA, Stewart WC, Stephens JM. Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo. Obesity (Silver Spring) 2011; 19:903 - 10; http://dx.doi.org/10.1038/oby.2010.293; PMID: 21164505
   PubMed Web of Science ®Google Scholar
• Zvonic S, Story DJ, Stephens JM, Mynatt RL. Growth hormone, but not insulin, activates STAT5 proteins in adipocytes in vitro and in vivo. Biochem Biophys Res Commun 2003; 302:359 - 62; http://dx.doi.org/10.1016/S0006-291X(03)00179-7; PMID: 12604355
   PubMed Web of Science ®Google Scholar
• Zvonic S, Baugh JE Jr., Arbour-Reily P, Mynatt RL, Stephens JM. Cross-talk among gp130 cytokines in adipocytes. J Biol Chem 2005; 280:33856 - 63; http://dx.doi.org/10.1074/jbc.M508020200; PMID: 16096272
   PubMed Web of Science ®Google Scholar
• Bates SH, Kulkarni RN, Seifert M, Myers MG Jr.. Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis. Cell Metab 2005; 1:169 - 78; http://dx.doi.org/10.1016/j.cmet.2005.02.001; PMID: 16054060
   PubMed Web of Science ®Google Scholar
• Buettner C, Pocai A, Muse ED, Etgen AM, Myers MG Jr., Rossetti L. Critical role of STAT3 in leptin’s metabolic actions. Cell Metab 2006; 4:49 - 60; http://dx.doi.org/10.1016/j.cmet.2006.04.014; PMID: 16814732
   PubMed Web of Science ®Google Scholar
• Gong Y, Ishida-Takahashi R, Villanueva EC, Fingar DC, Münzberg H, Myers MG Jr.. The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms. J Biol Chem 2007; 282:31019 - 27; http://dx.doi.org/10.1074/jbc.M702838200; PMID: 17726024
   PubMed Web of Science ®Google Scholar
• Piper ML, Unger EK, Myers MG Jr., Xu AW. Specific physiological roles for signal transducer and activator of transcription 3 in leptin receptor-expressing neurons. Mol Endocrinol 2008; 22:751 - 9; http://dx.doi.org/10.1210/me.2007-0389; PMID: 18096691
   PubMed Web of Science ®Google Scholar
• Flower L, Gray R, Pinkney J, Mohamed-Ali V. Stimulation of interleukin-6 release by interleukin-1beta from isolated human adipocytes. Cytokine 2003; 21:32 - 7; http://dx.doi.org/10.1016/S1043-4666(02)00495-7; PMID: 12668157
   PubMed Web of Science ®Google Scholar
• Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83:847 - 50; http://dx.doi.org/10.1210/jc.83.3.847; PMID: 9506738
   PubMed Web of Science ®Google Scholar
• Natal C, Fortuño MA, Restituto P, Bazán A, Colina I, Díez J, et al. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am J Physiol Endocrinol Metab 2008; 294:E52 - 60; http://dx.doi.org/10.1152/ajpendo.00506.2007; PMID: 17940213
   PubMed Web of Science ®Google Scholar
• Brandebourg T, Hugo E, Ben-Jonathan N. Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes Metab 2007; 9:464 - 76; http://dx.doi.org/10.1111/j.1463-1326.2006.00671.x; PMID: 17587388
   PubMed Web of Science ®Google Scholar
• Hugo ER, Brandebourg TD, Comstock CE, Gersin KS, Sussman JJ, Ben-Jonathan N. LS14: a novel human adipocyte cell line that produces prolactin. Endocrinology 2006; 147:306 - 13; http://dx.doi.org/10.1210/en.2005-0989; PMID: 16195405
   PubMed Web of Science ®Google Scholar
• Hugo ER, Borcherding DC, Gersin KS, Loftus J, Ben-Jonathan N. Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. J Clin Endocrinol Metab 2008; 93:4006 - 12; http://dx.doi.org/10.1210/jc.2008-1172; PMID: 18647802
   PubMed Web of Science ®Google Scholar
• McFarland-Mancini M, Hugo E, Loftus J, Ben-Jonathan N. Induction of prolactin expression and release in human preadipocytes by cAMP activating ligands. Biochem Biophys Res Commun 2006; 344:9 - 16; http://dx.doi.org/10.1016/j.bbrc.2006.03.168; PMID: 16630538
   PubMed Web of Science ®Google Scholar
• O’Rourke RW, Metcalf MD, White AE, Madala A, Winters BR, Maizlin II, et al. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int J Obes (Lond) 2009; 33:978 - 90; http://dx.doi.org/10.1038/ijo.2009.133; PMID: 19564875
   PubMed Web of Science ®Google Scholar
• Duffaut C, Zakaroff-Girard A, Bourlier V, Decaunes P, Maumus M, Chiotasso P, et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler Thromb Vasc Biol 2009; 29:1608 - 14; http://dx.doi.org/10.1161/ATVBAHA.109.192583; PMID: 19644053
   PubMed Web of Science ®Google Scholar
• Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008; 103:467 - 76; http://dx.doi.org/10.1161/CIRCRESAHA.108.177105; PMID: 18658050
   PubMed Web of Science ®Google Scholar
• Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) 2010; 18:1918 - 25; http://dx.doi.org/10.1038/oby.2010.1; PMID: 20111012
   PubMed Web of Science ®Google Scholar
• Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway F, et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol 2010; 185:1836 - 45; http://dx.doi.org/10.4049/jimmunol.1000021; PMID: 20581149
   PubMed Web of Science ®Google Scholar
• Grégoire F, De Broux N, Hauser N, Heremans H, Van Damme J, Remacle C. Interferon-gamma and interleukin-1 beta inhibit adipoconversion in cultured rodent preadipocytes. J Cell Physiol 1992; 151:300 - 9; http://dx.doi.org/10.1002/jcp.1041510211; PMID: 1572904
   PubMed Web of Science ®Google Scholar
• Keay S, Grossberg SE. Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes. Proc Natl Acad Sci U S A 1980; 77:4099 - 103; http://dx.doi.org/10.1073/pnas.77.7.4099; PMID: 6159626
   PubMed Web of Science ®Google Scholar
• McGillicuddy FC, Chiquoine EH, Hinkle CC, Kim RJ, Shah R, Roche HM, et al. Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem 2009; 284:31936 - 44; http://dx.doi.org/10.1074/jbc.M109.061655; PMID: 19776010
   PubMed Web of Science ®Google Scholar
• Waite KJ, Floyd ZE, Arbour-Reily P, Stephens JM. Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes. J Biol Chem 2001; 276:7062 - 8; http://dx.doi.org/10.1074/jbc.M007894200; PMID: 11106650
   PubMed Web of Science ®Google Scholar
• Floyd ZE, Stephens JM. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J Biol Chem 2002; 277:4062 - 8; http://dx.doi.org/10.1074/jbc.M108473200; PMID: 11733495
   PubMed Web of Science ®Google Scholar
• Meirhaeghe A, Fajas L, Gouilleux F, Cottel D, Helbecque N, Auwerx J, et al. A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population. Arterioscler Thromb Vasc Biol 2003; 23:289 - 94; http://dx.doi.org/10.1161/01.ATV.0000051382.28752.FE; PMID: 12588773
   PubMed Web of Science ®Google Scholar
• Hogan JC, Stephens JM. The identification and characterization of a STAT 1 binding site in the PPARgamma2 promoter. Biochem Biophys Res Commun 2001; 287:484 - 92; http://dx.doi.org/10.1006/bbrc.2001.5606; PMID: 11554754
   PubMed Web of Science ®Google Scholar
• Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999; 402:880 - 3; PMID: 10622252
   PubMed Web of Science ®Google Scholar
• Koivisto VA, Pelkonen R, Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 1989; 38:641 - 7; http://dx.doi.org/10.2337/diabetes.38.5.641; PMID: 2653935
   PubMed Web of Science ®Google Scholar
• Shiba T, Higashi N, Nishimura Y. Hyperglycaemia due to insulin resistance caused by interferon-gamma. Diabet Med 1998; 15:435 - 6; http://dx.doi.org/10.1002/(SICI)1096-9136(199805)15:5<435::AID-DIA566>3.0.CO;2-N; PMID: 9609368
   PubMed Web of Science ®Google Scholar
• Hogan JC, Stephens JM. STAT 1 binds to the LPL promoter in vitro. Biochem Biophys Res Commun 2003; 307:350 - 4; http://dx.doi.org/10.1016/S0006-291X(03)01198-7; PMID: 12859963
   PubMed Web of Science ®Google Scholar
• Doerrler W, Feingold KR, Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 1994; 6:478 - 84; http://dx.doi.org/10.1016/1043-4666(94)90074-4; PMID: 7827285
   PubMed Web of Science ®Google Scholar
• Balhoff JP, Stephens JM. Highly specific and quantitative activation of STATs in 3T3-L1 adipocytes. Biochem Biophys Res Commun 1998; 247:894 - 900; http://dx.doi.org/10.1006/bbrc.1998.8890; PMID: 9647789
   PubMed Web of Science ®Google Scholar
• Stephens JM, Lumpkin SJ, Fishman JB. Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes. J Biol Chem 1998; 273:31408 - 16; http://dx.doi.org/10.1074/jbc.273.47.31408; PMID: 9813052
   PubMed Web of Science ®Google Scholar
• Deng J, Hua K, Lesser SS, Greiner AH, Walter AW, Marrero MB, et al. Interleukin-4 mediates STAT6 activation in 3T3-L1 preadipocytes but not adipocytes. Biochem Biophys Res Commun 2000; 267:516 - 20; http://dx.doi.org/10.1006/bbrc.1999.1993; PMID: 10631093
   PubMed Web of Science ®Google Scholar
• Coulter AA, Stephens JM. STAT5 activators modulate acyl CoA oxidase (AOX) expression in adipocytes and STAT5A binds to the AOX promoter in vitro. Biochem Biophys Res Commun 2006; 344:1342 - 5; http://dx.doi.org/10.1016/j.bbrc.2006.04.071; PMID: 16650827
   PubMed Web of Science ®Google Scholar
• Nanbu-Wakao R, Fujitani Y, Masuho Y, Muramatu M, Wakao H. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol Endocrinol 2000; 14:307 - 16; http://dx.doi.org/10.1210/me.14.2.307; PMID: 10674402
   PubMed Web of Science ®Google Scholar
• Richter HE, Albrektsen T, Billestrup N. The role of signal transducer and activator of transcription 5 in the inhibitory effects of GH on adipocyte differentiation. J Mol Endocrinol 2003; 30:139 - 50; http://dx.doi.org/10.1677/jme.0.0300139; PMID: 12683938
   PubMed Web of Science ®Google Scholar
• Hogan JC, Stephens JM. The regulation of fatty acid synthase by STAT5A. Diabetes 2005; 54:1968 - 75; http://dx.doi.org/10.2337/diabetes.54.7.1968; PMID: 15983196
   PubMed Web of Science ®Google Scholar
• White UA, Coulter AA, Miles TK, Stephens JM. The STAT5A-mediated induction of pyruvate dehydrogenase kinase 4 expression by prolactin or growth hormone in adipocytes. Diabetes 2007; 56:1623 - 9; http://dx.doi.org/10.2337/db06-1286; PMID: 17360981
   PubMed Web of Science ®Google Scholar
• Zvonic S, Hogan JC, Arbour-Reily P, Mynatt RL, Stephens JM. Effects of cardiotrophin on adipocytes. J Biol Chem 2004; 279:47572 - 9; http://dx.doi.org/10.1074/jbc.M403998200; PMID: 15339920
   PubMed Web of Science ®Google Scholar
• Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol Endocrinol 1996; 10:519 - 33; http://dx.doi.org/10.1210/me.10.5.519; PMID: 8732683
   PubMed Web of Science ®Google Scholar
• Tenney R, Stansfield K, Pekala PH. Interleukin 11 signaling in 3T3-L1 adipocytes. J Cell Physiol 2005; 202:160 - 6; http://dx.doi.org/10.1002/jcp.20100; PMID: 15389536
   PubMed Web of Science ®Google Scholar
• Hogan JC, Stephens JM. Effects of leukemia inhibitory factor on 3T3-L1 adipocytes. J Endocrinol 2005; 185:485 - 96; http://dx.doi.org/10.1677/joe.1.05980; PMID: 15930175
   PubMed Web of Science ®Google Scholar
• Ott V, Fasshauer M, Dalski A, Klein HH, Klein J. Direct effects of ciliary neurotrophic factor on brown adipocytes: evidence for a role in peripheral regulation of energy homeostasis. J Endocrinol 2002; 173:R1 - 8; http://dx.doi.org/10.1677/joe.0.173R001; PMID: 12010646
   PubMedGoogle Scholar
• Zvonic S, Cornelius P, Stewart WC, Mynatt RL, Stephens JM. The regulation and activation of ciliary neurotrophic factor signaling proteins in adipocytes. J Biol Chem 2003; 278:2228 - 35; http://dx.doi.org/10.1074/jbc.M205871200; PMID: 12424252
   PubMed Web of Science ®Google Scholar
• Andersson CX, Sopasakis VR, Wallerstedt E, Smith U. Insulin antagonizes interleukin-6 signaling and is anti-inflammatory in 3T3-L1 adipocytes. J Biol Chem 2007; 282:9430 - 5; http://dx.doi.org/10.1074/jbc.M609980200; PMID: 17267401
   PubMed Web of Science ®Google Scholar
• Miyaoka Y, Tanaka M, Naiki T, Miyajima A. Oncostatin M inhibits adipogenesis through the RAS/ERK and STAT5 signaling pathways. J Biol Chem 2006; 281:37913 - 20; http://dx.doi.org/10.1074/jbc.M606089200; PMID: 17028188
   PubMed Web of Science ®Google Scholar
• Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278:45777 - 84; http://dx.doi.org/10.1074/jbc.M301977200; PMID: 12952969
   PubMed Web of Science ®Google Scholar
• White UA, Stewart WC, Mynatt RL, Stephens JM. Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes. J Biol Chem 2008; 283:22505 - 12; http://dx.doi.org/10.1074/jbc.M710462200; PMID: 18562323
   PubMed Web of Science ®Google Scholar
• White UA, Stephens JM. Neuropoietin activates STAT3 independent of LIFR activation in adipocytes. Biochem Biophys Res Commun 2010; 395:48 - 50; http://dx.doi.org/10.1016/j.bbrc.2010.03.132; PMID: 20353755
   PubMed Web of Science ®Google Scholar
• White UA, Stephens JM. The gp130 receptor cytokine family: regulators of adipocyte development and function. Curr Pharm Des 2011; 17:340 - 6; http://dx.doi.org/10.2174/138161211795164202; PMID: 21375496
   PubMed Web of Science ®Google Scholar
• Fleenor D, Arumugam R, Freemark M. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm Res 2006; 66:101 - 10; http://dx.doi.org/10.1159/000093667; PMID: 16735796
   PubMed Web of Science ®Google Scholar
• Story DJ, Stephens JM. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes. Obesity (Silver Spring) 2006; 14:1303 - 11; http://dx.doi.org/10.1038/oby.2006.148; PMID: 16988072
   PubMed Web of Science ®Google Scholar